[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Deferiprone Market by Manufacturers, Countries, Type and Application, Forecast to 2022

September 2017 | 115 pages | ID: NB12BD2AE94EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload

SCOPE OF THE REPORT:

This report focuses on the Deferiprone in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
  • Apotex
  • Cipla
Market Segment by Countries, covering
  • United States
  • Canada
  • Mexico
Market Segment by Type, covers
  • Tablet
  • Oral Solution
  • Capsule
Market Segment by Applications, can be divided into
  • Transfusional Iron Overload
  • NTDT Caused Iron Overload
There are 15 Chapters to deeply display the North America Deferiprone market.

Chapter 1, to describe Deferiprone Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Deferiprone, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Deferiprone, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Deferiprone market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Deferiprone Research Findings and Conclusion, Appendix, methodology and data source
1 MARKET OVERVIEW

1.1 Deferiprone Introduction
1.2 Market Analysis by Type
  1.2.1 Tablet
  1.2.2 Oral Solution
  1.2.3 Capsule
1.3 Market Analysis by Applications
  1.3.1 Transfusional Iron Overload
  1.3.2 NTDT Caused Iron Overload
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Apotex
  2.1.1 Profile
  2.1.2 Deferiprone Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Apotex Deferiprone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Apotex News
2.2 Cipla
  2.2.1 Profile
  2.2.2 Deferiprone Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Cipla Deferiprone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Cipla News

3 NORTH AMERICA DEFERIPRONE MARKET COMPETITION, BY MANUFACTURER

3.1 North America Deferiprone Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Deferiprone Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Deferiprone Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Deferiprone Manufacturer Market Share
  3.4.2 Top 5 Deferiprone Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA DEFERIPRONE MARKET ANALYSIS BY COUNTRIES

4.1 North America Deferiprone Sales Market Share by Countries
4.2 North America Deferiprone Sales by Countries (2012-2017)
4.3 North America Deferiprone Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION DEFERIPRONE BY TYPE

5.1 North America Deferiprone Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Deferiprone Sales and Market Share by Type (2012-2017)
  5.1.2 North America Deferiprone Revenue and Market Share by Type (2012-2017)
5.2 Tablet Sales Growth and Price
  5.2.1 North America Tablet Sales Growth (2012-2017)
  5.2.2 North America Tablet Price (2012-2017)
5.3 Oral Solution Sales Growth and Price
  5.3.1 North America Oral Solution Sales Growth (2012-2017)
  5.3.2 North America Oral Solution Price (2012-2017)
5.4 Capsule Sales Growth and Price
  5.4.1 North America Capsule Sales Growth (2012-2017)
  5.4.2 North America Capsule Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION DEFERIPRONE BY APPLICATION

6.1 North America Deferiprone Sales Market Share by Application (2012-2017)
6.2 Transfusional Iron Overload Sales Growth (2012-2017)
6.3 NTDT Caused Iron Overload Sales Growth (2012-2017)

7 UNITED STATES DEFERIPRONE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Deferiprone Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Deferiprone Sales and Market Share by Type
7.3 United States Deferiprone Sales by Application (2012-2017)
7.4 United States Deferiprone Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Deferiprone Sales and Market Share by Manufacturer
  7.4.2 United States Deferiprone Revenue and Market Share by Manufacturer
7.5 United States Deferiprone Export and Import (2012-2017)

8 CANADA DEFERIPRONE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Deferiprone Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Deferiprone Sales and Market Share by Type
8.3 Canada Deferiprone Sales by Application (2012-2017)
8.4 Canada Deferiprone Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Deferiprone Sales and Market Share by Manufacturer
  8.4.2 Canada Deferiprone Revenue and Market Share by Manufacturer
8.5 Canada Deferiprone Export and Import (2012-2017)

9 MEXICO DEFERIPRONE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Deferiprone Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Deferiprone Sales and Market Share by Type
9.3 Mexico Deferiprone Sales by Application (2012-2017)
9.4 Mexico Deferiprone Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Deferiprone Sales and Market Share by Manufacturer
  9.4.2 Mexico Deferiprone Revenue and Market Share by Manufacturer
9.5 Mexico Deferiprone Export and Import (2012-2017)

10 DEFERIPRONE MARKET FORECAST (2017-2022)

10.1 North America Deferiprone Sales, Revenue and Growth Rate (2017-2022)
10.2 Deferiprone Market Forecast by Countries (2017-2022)
  10.2.1 United States Deferiprone Forecast (2017-2022)
  10.2.2 Canada Deferiprone Forecast (2017-2022)
  10.2.3 Mexico Deferiprone Forecast (2017-2022)
10.3 Deferiprone Market Forecast by Type (2017-2022)
10.4 Deferiprone Market Forecast by Application (2017-2022)

11 DEFERIPRONE MANUFACTURING COST ANALYSIS

11.1 Deferiprone Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Deferiprone

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Deferiprone Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Deferiprone Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
LIST OF TABLES AND FIGURES

Figure Deferiprone Picture
Table Product Specifications of Deferiprone
Figure North America Sales Market Share of Deferiprone by Types in 2016
Table Types of Deferiprone
Figure Tablet Picture
Table Major Manufacturers of Tablet
Figure Oral Solution Picture
Table Major Manufacturers of Oral Solution
Figure Capsule Picture
Table Major Manufacturers of Capsule
Table North America Deferiprone Sales Market Share by Applications in 2016
Table Applications of Deferiprone
Figure Transfusional Iron Overload Picture
Figure NTDT Caused Iron Overload Picture
Figure United States Deferiprone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Deferiprone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Deferiprone Revenue (Million USD) and Growth Rate (2012-2022)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Deferiprone Type and Applications
Table Apotex Deferiprone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Deferiprone Type and Applications
Table Cipla Deferiprone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Deferiprone Sales by Manufacturer (2016-2017)
Figure North America Deferiprone Sales Market Share by Manufacturer in 2016
Figure North America Deferiprone Sales Market Share by Manufacturer in 2017
Table North America Deferiprone Revenue by Manufacturer (2016-2017)
Figure North America Deferiprone Revenue Market Share by Manufacturer in 2016
Figure North America Deferiprone Revenue Market Share by Manufacturer in 2017
Table North America Deferiprone Price by Manufacturers (2016-2017)
Figure Top 3 Deferiprone Manufacturer Market Share in 2016
Figure Top 3 Deferiprone Manufacturer Market Share in 2017
Figure Top 5 Deferiprone Manufacturer Market Share in 2016
Figure Top 5 Deferiprone Manufacturer Market Share in 2017
Figure North America Deferiprone Sales and Growth (2012-2017)
Table North America Deferiprone Sales by Countries (2012-2017)
Table North America Deferiprone Sales Market Share by Countries (2012-2017)
Figure North America 2012 Deferiprone Sales Market Share by Countries
Figure North America 2016 Deferiprone Sales Market Share by Countries
Figure North America Deferiprone Revenue and Growth (2012-2017)
Table North America Deferiprone Revenue by Countries (2012-2017)
Table North America Deferiprone Revenue Market Share by Countries (2012-2017)
Table North America 2012 Deferiprone Revenue Market Share by Countries
Table North America 2016 Deferiprone Revenue Market Share by Countries
Table North America Deferiprone Sales by Type (2012-2017)
Table North America Deferiprone Sales Share by Type (2012-2017)
Table North America Deferiprone Revenue by Type (2012-2017)
Table North America Deferiprone Revenue Share by Type (2012-2017)
Figure North America Tablet Sales Growth (2012-2017)
Figure North America Tablet Price (2012-2017)
Figure North America Oral Solution Sales Growth (2012-2017)
Figure North America Oral Solution Price (2012-2017)
Figure North America Capsule Sales Growth (2012-2017)
Figure North America Capsule Price (2012-2017)
Table North America Deferiprone Sales by Application (2012-2017)
Table North America Deferiprone Sales Share by Application (2012-2017)
Figure North America Transfusional Iron Overload Sales Growth (2012-2017)
Figure North America NTDT Caused Iron Overload Sales Growth (2012-2017)
Figure United States Deferiprone Revenue and Growth (2012-2017)
Figure United States Deferiprone Sales and Growth (2012-2017)
Table United States Deferiprone Sales by Type (2012-2017)
Table United States Deferiprone Sales Market Share by Type (2012-2017)
Table United States Deferiprone Sales by Application (2012-2017)
Table United States Deferiprone Sales Market Share by Application (2012-2017)
Table United States Deferiprone Sales by Manufacturer (2016-2017)
Figure United States Deferiprone Sales Market Share by Manufacturer in 2016
Figure United States Deferiprone Sales Market Share by Manufacturer in 2017
Table United States Deferiprone Revenue by Manufacturer (2016-2017)
Figure United States Deferiprone Revenue Market Share by Manufacturer in 2016
Figure United States Deferiprone Revenue Market Share by Manufacturer in 2017
Table United States Deferiprone Export and Import (2012-2017)
Figure Canada Deferiprone Revenue and Growth (2012-2017)
Figure Canada Deferiprone Sales and Growth (2012-2017)
Table Canada Deferiprone Sales by Type (2012-2017)
Table Canada Deferiprone Sales Market Share by Type (2012-2017)
Table Canada Deferiprone Sales by Application (2012-2017)
Table Canada Deferiprone Sales Market Share by Application (2012-2017)
Table Canada Deferiprone Sales by Manufacturer (2016-2017)
Figure Canada Deferiprone Sales Market Share by Manufacturer in 2016
Figure Canada Deferiprone Sales Market Share by Manufacturer in 2017
Table Canada Deferiprone Revenue by Manufacturer (2016-2017)
Figure Canada Deferiprone Revenue Market Share by Manufacturer in 2016
Figure Canada Deferiprone Revenue Market Share by Manufacturer in 2017
Table Canada Deferiprone Export and Import (2012-2017)
Figure Mexico Deferiprone Revenue and Growth (2012-2017)
Figure Mexico Deferiprone Sales and Growth (2012-2017)
Table Mexico Deferiprone Sales by Type (2012-2017)
Table Mexico Deferiprone Sales Market Share by Type (2012-2017)
Table Mexico Deferiprone Sales by Application (2012-2017)
Table Mexico Deferiprone Sales Market Share by Application (2012-2017)
Table Mexico Deferiprone Sales by Manufacturer (2016-2017)
Figure Mexico Deferiprone Sales Market Share by Manufacturer in 2016
Figure Mexico Deferiprone Sales Market Share by Manufacturer in 2017
Table Mexico Deferiprone Revenue by Manufacturer (2016-2017)
Figure Mexico Deferiprone Revenue Market Share by Manufacturer in 2016
Figure Mexico Deferiprone Revenue Market Share by Manufacturer in 2017
Table Mexico Deferiprone Export and Import (2012-2017)
Figure North America Deferiprone Sales, Revenue and Growth Rate (2017-2022)
Table North America Deferiprone Sales Forecast by Countries (2017-2022)
Table North America Deferiprone Market Share Forecast by Countries (2017-2022)
Figure United States Deferiprone Sales Forecast (2017-2022)
Figure Canada Deferiprone Sales Forecast (2017-2022)
Figure Mexico Deferiprone Sales Forecast (2017-2022)
Table North America Deferiprone Sales Forecast by Type (2017-2022)
Table North America Deferiprone Market Share Forecast by Type (2017-2022)
Table North America Deferiprone Sales Forecast by Application (2017-2022)
Table North America Deferiprone Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Deferiprone
Figure Manufacturing Process Analysis of Deferiprone
Figure Deferiprone Industrial Chain Analysis
Table Raw Materials Sources of Deferiprone Major Manufacturers in 2016
Table Major Buyers of Deferiprone
Table Distributors/Traders/ Dealers List


More Publications